Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 8 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 24 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 27 |
NetGPI | no | yes: 0, no: 27 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005886 | plasma membrane | 3 | 1 |
GO:0016020 | membrane | 2 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
GO:0031253 | cell projection membrane | 4 | 1 |
GO:0060170 | ciliary membrane | 5 | 1 |
GO:0098588 | bounding membrane of organelle | 4 | 1 |
GO:0098590 | plasma membrane region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HZL5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 197 | 201 | PF00656 | 0.292 |
CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.561 |
CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.368 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.495 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.536 |
CLV_PCSK_FUR_1 | 24 | 28 | PF00082 | 0.500 |
CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.524 |
CLV_PCSK_KEX2_1 | 168 | 170 | PF00082 | 0.417 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.402 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.498 |
CLV_PCSK_PC1ET2_1 | 127 | 129 | PF00082 | 0.488 |
CLV_PCSK_PC1ET2_1 | 26 | 28 | PF00082 | 0.422 |
CLV_PCSK_PC7_1 | 123 | 129 | PF00082 | 0.291 |
CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.406 |
CLV_PCSK_SKI1_1 | 194 | 198 | PF00082 | 0.456 |
CLV_PCSK_SKI1_1 | 27 | 31 | PF00082 | 0.444 |
CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.462 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.486 |
DOC_CYCLIN_RxL_1 | 151 | 159 | PF00134 | 0.347 |
DOC_MAPK_gen_1 | 6 | 13 | PF00069 | 0.558 |
DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.453 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.468 |
DOC_USP7_MATH_1 | 204 | 208 | PF00917 | 0.376 |
DOC_USP7_MATH_1 | 35 | 39 | PF00917 | 0.412 |
DOC_USP7_MATH_1 | 46 | 50 | PF00917 | 0.425 |
DOC_USP7_UBL2_3 | 154 | 158 | PF12436 | 0.481 |
DOC_USP7_UBL2_3 | 26 | 30 | PF12436 | 0.295 |
DOC_USP7_UBL2_3 | 8 | 12 | PF12436 | 0.470 |
LIG_14-3-3_CanoR_1 | 151 | 157 | PF00244 | 0.369 |
LIG_14-3-3_CanoR_1 | 194 | 202 | PF00244 | 0.332 |
LIG_Actin_WH2_2 | 209 | 226 | PF00022 | 0.494 |
LIG_BRCT_BRCA1_1 | 60 | 64 | PF00533 | 0.433 |
LIG_FHA_1 | 109 | 115 | PF00498 | 0.508 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.308 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.536 |
LIG_FHA_2 | 135 | 141 | PF00498 | 0.505 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.468 |
LIG_FHA_2 | 195 | 201 | PF00498 | 0.561 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.419 |
LIG_LIR_Apic_2 | 226 | 232 | PF02991 | 0.346 |
LIG_LIR_Gen_1 | 61 | 71 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 134 | 138 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 61 | 67 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 94 | 99 | PF02991 | 0.450 |
LIG_LYPXL_yS_3 | 70 | 73 | PF13949 | 0.334 |
LIG_Rb_pABgroove_1 | 112 | 120 | PF01858 | 0.314 |
LIG_SH2_PTP2 | 229 | 232 | PF00017 | 0.344 |
LIG_SH2_STAP1 | 162 | 166 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.341 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.344 |
LIG_SH3_3 | 68 | 74 | PF00018 | 0.521 |
LIG_Sin3_3 | 81 | 88 | PF02671 | 0.249 |
LIG_UBA3_1 | 4 | 12 | PF00899 | 0.572 |
MOD_CK1_1 | 207 | 213 | PF00069 | 0.320 |
MOD_CK1_1 | 38 | 44 | PF00069 | 0.432 |
MOD_CK2_1 | 134 | 140 | PF00069 | 0.461 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.512 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.443 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.480 |
MOD_GlcNHglycan | 214 | 219 | PF01048 | 0.361 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.462 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.412 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.474 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.456 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.419 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.436 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.318 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.456 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.437 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.536 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.467 |
MOD_NEK2_2 | 46 | 51 | PF00069 | 0.571 |
MOD_PKA_1 | 144 | 150 | PF00069 | 0.423 |
MOD_PKA_2 | 150 | 156 | PF00069 | 0.510 |
MOD_Plk_1 | 103 | 109 | PF00069 | 0.410 |
MOD_Plk_2-3 | 134 | 140 | PF00069 | 0.463 |
MOD_Plk_4 | 103 | 109 | PF00069 | 0.396 |
MOD_Plk_4 | 152 | 158 | PF00069 | 0.383 |
MOD_SUMO_rev_2 | 177 | 183 | PF00179 | 0.543 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.461 |
TRG_ER_diArg_1 | 24 | 27 | PF00400 | 0.502 |
TRG_ER_diArg_1 | 50 | 52 | PF00400 | 0.315 |
TRG_Pf-PMV_PEXEL_1 | 51 | 55 | PF00026 | 0.496 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4S1 | Leptomonas seymouri | 56% | 100% |
A0A0N1PD85 | Leptomonas seymouri | 34% | 100% |
A0A0N1PG41 | Leptomonas seymouri | 24% | 77% |
A0A1X0NEE3 | Trypanosomatidae | 24% | 89% |
A0A1X0NFG5 | Trypanosomatidae | 24% | 89% |
A0A1X0NXA6 | Trypanosomatidae | 27% | 81% |
A0A1X0NXA8 | Trypanosomatidae | 36% | 100% |
A0A3Q8IKU7 | Leishmania donovani | 32% | 100% |
A0A3S5H792 | Leishmania donovani | 100% | 100% |
A0A3S5H7I1 | Leishmania donovani | 24% | 72% |
A0A422MZP2 | Trypanosoma rangeli | 27% | 81% |
A4HBJ9 | Leishmania braziliensis | 34% | 100% |
A4HBK0 | Leishmania braziliensis | 63% | 100% |
A4HFU7 | Leishmania braziliensis | 22% | 72% |
A4HZL6 | Leishmania infantum | 32% | 100% |
A4I2W4 | Leishmania infantum | 24% | 72% |
E9ADF0 | Leishmania major | 21% | 72% |
E9AHL0 | Leishmania infantum | 24% | 79% |
E9AUW8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
E9AUW9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
E9AZ74 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 72% |
Q4Q6I6 | Leishmania major | 25% | 100% |
Q4QCL3 | Leishmania major | 87% | 100% |
Q4QCL4 | Leishmania major | 32% | 100% |
V5BG41 | Trypanosoma cruzi | 38% | 100% |
V5BKK3 | Trypanosoma cruzi | 25% | 81% |